Aakash Desai, MD
@akMD03
Followers
300
Following
922
Media
6
Statuses
120
GI-IBD & Assoc. Program Director @AHNGastro || Assistant Prof. of Medicine @DrexelMedicine || Alumni @MayoClinicFLGIH @metrohealthCLE @cwrusom
Pittsburgh, PA
Joined June 2019
RT @IJG_Journal: Efficacy of tirzepatide for weight loss and it’s comparative effectiveness to weight loss surgery in inflammatory bowel di….
0
4
0
Welcome to our new 1st year fellows! Excited to be a part of your fellowship journey. Looking forward to working with all our fellows this year!.
Gut feeling says these 1st year GI fellows are going to be AMAZING! 🎉 Big welcome to Dr. Jacubowsky, Dr. Gries, Dr. Cohen & Dr. Amin! Plus, HUGE congrats to @AkashGadaniMD, our new Program Director, & @akMD03, our new Associate Program Director! #GIFellows #GI #AHNToday
0
0
11
RT @GKochharMD: Not all patients with #UC may need biological therapy but how do we know which ones do and how we counsel our #patients on….
pubmed.ncbi.nlm.nih.gov
Our study provides updated estimates of advanced therapy utilization and colectomy as well as predictors of disease progression in patients with UC on 5-ASA in the biologic era.
0
4
0
RT @NabeehaMohyudd1: Join us NEXT Saturday at the BEST conference (I’m biased 😆)as we learn from @ebtapper @NoureddinMD @DrJessicaDavis @sh….
0
9
0
RT @NabeehaMohyudd1: Less than a month left for the @AHNGastro GI and Liver Conference. 4/5/2025. Fairmont in Pittsburgh, PA. Registration….
0
11
0
We are honored to receive this award from @IBDJournals and @CrohnsColitisFn! Incredibly fortunate to have @GKochharMD as a mentor. Thank you to all the co-authors for their support and expertise @FarrayeIBD @JHashashMD @MRegueiroMD.
Our team won the #best clinical research award. Thanks to @IBDJournals and @CrohnsColitisFn a great team effort but a special Shout out to my colleague and partner @akMD03 for his dedication and hardwork. A true rising star in the field of #obesity and #Ibd @AHNGastro @AHNtoday
1
3
14
Great collaboration between @MilestoneIBD alumni @phillyIBDdoc .Thank you to @APandT for publishing our work! @GKochharMD @FarrayeIBD @Himsikhar1 @AHNGastro.
Patients with obesity and ulcerative colitis are at an increased risk of composite outcome of steroid use, change in advanced therapy and colectomy. Read the paper by Desai et al at #obesity #ulcerativecolitis #IBD #GItwitter
0
2
16
RT @phillyIBDdoc: Excited to share: Obesity assoc w worse outcomes in UC @APandT . @akMD03 @JamesLewisGIEpi @PennIBDDoc @GKochharMD @Farray….
pubmed.ncbi.nlm.nih.gov
Obesity is associated with lower efficacy of several advanced therapies in patients with UC.
0
8
0
RT @GKochharMD: Use of #EFTR in management of #dysplasia #polyps in patients with #IBD .Initial experience .It is still early days, but it….
pubmed.ncbi.nlm.nih.gov
Kochhar G - Search Results - PubMed
0
5
0
RT @GKochharMD: Check out our new #publication looking at Ozanimod and Vedolizumab in patients with #ulcerativecolitis #ibd #bigdata from ….
pubmed.ncbi.nlm.nih.gov
Our real-world study showed that ozanimod use is associated with similar corticosteroid use but higher odds of a change in therapy compared to vedolizumab when used as first-line therapy in patients...
0
10
0
RT @Himsikhar1: From presenting 3️⃣ posters at Western PA ACP @ACPIMPhysicians to 1️⃣1️⃣ at @AmCollegeGastro over two back to back days, wi….
0
10
0
RT @ibdgijami: 💊Have you ever had a patient with #IBD who previously failed TOFA and wondered if there is opportunity to use UPA for treatm….
0
15
0
RT @GKochharMD: The burden of #IBD is high in young #women and is increasing. Read more about #epidemiology of IBD in our recent paper, led….
pubmed.ncbi.nlm.nih.gov
From 2010 to 2019, in the largest global epidemiology database, prevalence rates of inflammatory bowel disease in young females increased in many regions. Countries with lower socioeconomic develop...
0
5
0
RT @Achintya_singh4: What are the various endoscopic techniques to manage dysplasia in IBD❔. We summarized it for you!! . 🙏🙏 @GKochharMD….
0
5
0
RT @dr_fcalderaibd: New study: Patients with IBD at higher risk for RSV hospitalization (aOR 1.30). Key findings:.↑ risk in 18-49 & 65+ age….
journals.lww.com
ed risk of a serious infection due to RSV. METHODS: We conducted a retrospective study using the multi-institutional research network TriNetX to assess the risk of hospitalization in a cohort of...
0
12
0
Check out our comprehensive review on 🔦 approaches to management of dysplasia in IBD published in @IJG_Journal .Tremendous work by future 🌟 AEF @Achintya_singh4 under the mentorship of @GKochharMD.
Learn everything about #dysplasia in #ibd in our new paper @IJG_Journal @drvishal82 thank you for the opportunity to contribute!! .@AHNGastro @akMD03 .
0
3
11
RT @nataliesparacio: A look into the intriguing possibilities that lie at the intersection of weight loss & #IBD management. You’ll hear fr….
lightscameracrohns.com
Imagine a medication that not only helps shed unwanted pounds but also holds the promise of alleviating the painful and debilitating symptoms of inflammatory bowel disease (IBD). For millions battl…
0
6
0
RT @Himsikhar1: Honored to have 12 abstracts selected as first author, including 1 oral presentation, and 19+ abstracts overall at @AmColle….
0
12
0
RT @DCharabaty: #SundayRead☕️.All #JAKi are not=. 🔺UPA>TOFA in UC:⬇️ IV steroids &✂️ @12mos. 🚩IMO, Still a role for TOFA.✅Liquid PO form.✅P….
0
9
0
RT @Himsikhar1: 🚨 Excited to announce our new publication in the prestigious @AmJGastro ! . We compared the effectiveness of Upadacitinib v….
0
14
0